Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xuesaitong soft capsule for cognitive function in hypertension arteriosclerosis and cerebral small vessel disease
ChiCTR2200063618Phase 4Recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Jan 2022
- Countries
- 1
01
Overview
Phase 4, randomised trial in Cerebral Small Vessel Disease (CSVD) and arteriosclerosis comparing Experimental group: Xuesaitong soft capsule with Control group: placebo capsules (2 arms). Primary endpoints: MMSE score, Fazekas score and 2 more. Started Jan 2022; status: recruiting.
02
Drugs
panax notoginseng
03
Conditions
Cerebral Small Vessel Disease (CSVD)arteriosclerosis
Beyond the preview
Go deeper on ChiCTR2200063618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063618.